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Introduction: Few lung cancer studies have focused on lung can-
cer survival in underserved populations. We conducted a prospective 
cohort study among 81,697 racially diverse and medically under-
served adults enrolled in the Southern Community Cohort Study 
throughout an 11-state area of the Southeast from March 2002 to 
September 2009.
Methods: Using linkages with state cancer registries, we identified 
501 incident non–small-cell lung cancer cases. We applied Cox pro-
portional hazards models to estimate hazard ratios (HRs) and 95% 
confidence intervals (CIs) for subsequent mortality among black and 
white participants.
Results: The mean observed follow-up time (the time from diagnosis 
to death or end of follow-up) was 1.25 years (range, 0–8.3 years) and 
75% (n = 376) of cases died during follow-up. More blacks were 
diagnosed at distant stage than whites (57 versus 45%; p = 0.03). 
In multivariable analyses adjusted for pack-years of smoking, age, 
body mass index, health insurance, socioeconomic status and dis-
ease stage, the lung cancer mortality HR was higher for men versus 
women (HR = 1.41; 95% CI, 1.09–1.81) but similar for blacks versus 
whites (HR = 0.99; 95% CI, 0.74–1.32).
Conclusion: These findings suggest that although proportionally 
more blacks present with distant-stage disease there is no difference 
in stage-adjusted lung cancer mortality between blacks and whites of 
similar low socioeconomic status.
Key Words: Lung cancer, Race, Disparities, Survival, Socioeconomic 
status.
(J Thorac Oncol. 2013;8: 1248–1254)
Lung cancer is the leading cause of cancer-related mortality in the United States among men and women, with an over-
all 5-year relative survival of only 16%.1–3 According to the 
American Cancer Society, an estimated 160,340 lung cancer 
deaths occurred in the United States in 2012, accounting for 
28% of all cancer deaths.4 Although survival from lung can-
cer has improved since the early 1990s, racial differences in 
lung cancer survival persist such that blacks experience poorer 
5-year survival for lung cancer compared with whites.1,3,5–8 
Specifically, recent 5-year relative survival estimates from the 
Surveillance Epidemiology and End Results 18 areas indicates 
blacks have a 13.0% 5-year relative survival whereas whites 
have a 16.3% 5-year relative survival.3,9 Moreover, blacks are 
less likely to present with localized disease2,10 and also have a 
poorer prognosis even when diagnosed with localized disease, 
which is more successfully treated.2,11 Advanced stage of dis-
ease at diagnosis is the primary factor contributing to the poor 
prognosis of lung cancer, although other risk factors identified 
to date include low socioeconomic status (SES), male sex, and 
incomplete lung resection.12,13 Populations living in Southern 
United States experience the highest mortality for lung cancer, 
especially among men.2,6
Because of the high burden of lung cancer in under-
served populations,14 understanding lung cancer prognosis 
in these populations is necessary for targeted public health 
interventions for reducing lung cancer deaths. Moreover, the 
paucity of lung cancer studies conducted among minority and 
low-income populations emphasizes the need to understand 
lung cancer survival in these understudied populations. Using 
data from the Southern Community Cohort Study (SCCS),15,16 
which includes a large proportion of blacks and underserved 
low-income individuals, we examined whether lung cancer 
survival differs between socioeconomically similar white and 
black populations living in Southern United States.
PATIENTS AND METHODS
Study Population
The SCCS is an ongoing prospective cohort study estab-
lished to examine cancer disparities among a predominantly 
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low-income population. From March 2002 to September 2009, 
70,748 racially diverse adults were enrolled into the SCCS at 
community health centers, institutions providing basic health 
care and preventative services in medically underserved geo-
graphic areas, throughout an 11-state area of the Southeast 
(Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, 
Mississippi, North Carolina, South Carolina, Tennessee, and 
Virginia). Additional participants (n = 10,949) were enrolled 
from the same 11-state area into the SCCS by selecting a 
random sample of adults identified from voter registration, 
driver’s license records, and commercial records. Participants 
were aged 40 to 79 years at enrollment and approximately 
two thirds self-reported as black/African American. Extensive 
details of the SCCS study design and participant recruitment 
are summarized elsewhere.15,16 Briefly, participants were eli-
gible if they spoke English, were between the ages of 40 to 
79 years, and were not under treatment for cancer (except for 
nonmelanoma skin cancer) within the prior 12 months. For this 
analysis, participants were excluded if they had a prior diag-
nosis of lung cancer at cohort entry. The SCCS was approved 
by institutional review boards at Vanderbilt University and 
Meharry Medical College. Written informed consent was 
obtained from all participants.
Baseline Characteristics
Epidemiologic data were collected by trained interview-
ers during in-person computer-assisted personal interviews 
conducted at the community health centers or by mailed ques-
tionnaire from the random sample of the general population. 
Information was ascertained on demographic characteristics 
and exposure histories, including race/ethnicity, tobacco-smok-
ing history, medical history, and health insurance status. From 
March 2002 to September 2007, self-reported weight and height 
were ascertained from the baseline questionnaire administered 
by trained study interviewers. Participants were provided with 
the 2000 U.S. Census categories for race/ethnicity and asked to 
mark all that applied to their race and ethnic background.
Lung Cancer Case Identification 
and Mortality Assessment
Incident lung cancer cases (International Classification 
of Diseases for Oncology, 3rd edition, codes C340-C349) 
were identified via linkage with state cancer registries oper-
ating in the 11-state study area. Lung cancer stage and cell 
type were obtained from the state cancer registries. The cohort 
was followed up for all-cause mortality, with the number 
of survival days defined as the time from date of diagnosis 
until date of death, loss to follow-up or censoring, by linkage 
with the National Death Index through December 31, 2010 
and the Social Security Administration through February 4, 
2011. Cause of death was available only for deaths occurring 
through 2010.
Statistical Analysis
Lung cancer patients reporting races other than non-
Hispanic white or non-Hispanic black (n = 25) were excluded 
from analyses. Differences in baseline characteristics 
between black and white lung cancer cases were evalu-
ated using the χ2 test and two-sample t test for categorical 
or continuous variables, respectively. Kaplan–Meier curves 
were plotted to visualize survival probabilities, and differ-
ences in survival between whites and blacks were assessed 
using the log-rank test. We estimated hazard ratios (HRs) 
and accompanying 95% confidence intervals (CIs) for lung 
cancer mortality using Cox proportional hazard (PH) mod-
els, adjusted for demographic and clinical characteristics, 
to evaluate whether lung cancer survival differed between 
blacks and whites. Age of the participant at diagnosis was 
included as a covariate in Cox PH models. The PHs assump-
tion was assessed by including an interaction term between 
race and time and we found that hazards remained constant 
over time. We estimated odds ratios (ORs) for the associa-
tion between education and health insurance and stage of 
diagnosis (coded as local versus distant/regional), using 
multivariable logistic regression models. All analyses were 
conducted using SAS software, version 9.3 (SAS Institute, 
Inc., Cary, NC). Statistical tests were two-sided and an α of 
0.05 was used to assess statistical significance.
RESULTS
We identified 501 incident non–small-cell lung cancer 
cases (149 non-Hispanic white, 352 non-Hispanic black) 
occurring among the 81,697 participants during the follow-
up period from March 2002 to February 2011. During an 
average of 1.3 (maximum 8.3) years of follow-up, 376 deaths 
occurred and 309 (82%) had lung cancer as the primary 
cause of death. Most cases (88%) were recruited from com-
munity health centers. Among the lung cancer cases 66% 
had an annual household income less than $15,000, 42% had 
less than a high-school education, 58% were overweight or 
obese, 71% were current smokers, and 34% reported having 
no medical insurance at cohort entry, reflecting the overall 
demographics of the SCCS cohort.15 Approximately half 
(49%) of the lung cancer cases were diagnosed with distant-
stage lung cancer, whereas only 16% of cases were diag-
nosed at local stage. The most frequent histologic tumor type 
was adenocarcinoma (39%), followed by squamous cell car-
cinoma (27%), and non–small-cell not otherwise specified 
(27%), and other non–small-cell lung cancer tumors (e.g., 
large cell; 8%).
No differences were observed between black and white 
lung cancer cases for household income or smoking status 
(current/former/never smoker), the primary lung cancer risk 
factor (Table 1). More blacks smoked menthol cigarettes 
compared with whites. More whites self-reported a physi-
cian diagnosis of emphysema or chronic bronchitis and a 
first-degree relative with lung cancer. Health insurance status 
differed between blacks and whites (p = 0.007), with more 
blacks uninsured (36 versus 30%, respectively) and receiving 
Medicaid (25 versus 18%, respectively) than whites (Table 1). 
A greater percentage of blacks were diagnosed with distant-
stage lung cancer than whites (57 versus 45%, respectively; p 
= 0.03; Fig. 1). Histologic subtypes of disease did not differ 
between blacks and whites. The overall mean age at diagnosis 
for lung cancer cases was 60.0 years (SD, 8.9).
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TABLE 1.  Demographic Characteristics by Race of Incident NSCLC Cases Occurring in the Southern Community Cohort Study, 
2002–2011
Characteristic
NSCLC Cases
N = 501
Black (n = 352) White (n = 149)
n (%) n (%)
Sex
  Male 209 (59.4) 67 (45.0)
  Female 143 (40.6) 82 (55.0)
Vital statusa
  Died 270 (76.7) 106 (71.1)
  Alive 82 (23.3) 43 (28.9)
Person-years of follow-up 410.4 218.0
Lung cancer stage at diagnosis
  Distant 181 (56.9) 60 (45.5)
  Local 48 (15.1) 30 (22.7)
  Regional 89 (28.0) 42 (31.8)
  Unknown 51
Histology
  Adenocarcinoma 139 (39.5) 55 (36.9)
  Non–small-cell lung cancer-NOS 97 (27.6) 38 (25.5)
  Squamous 89 (25.3) 44 (29.5)
  Other NSCLC 27 (7.7) 12 (8.1)
Mean age at enrollment, yr (SD) 55.7 (8.8) 59.7 (8.8)
Mean age at diagnosis, yr (SD) 59.0 (8.7) 62.3 (9.0)
Mean observed duration of disease among those  
who died,b yr (SD)
0.74 (0.85) 0.82 (0.93)
Mean observed duration of disease among those  
alive at last follow-up,b year (SD)
2.57 (1.9) 3.05 (1.7)
Highest education level, yr
  <12 161 (45.9) 51 (34.5)
  ≥12 190 (54.1) 97 (65.5)
  Unknown 2
Household income in last year
  <$15,000 232 (66.5) 94 (63.9)
  ≥$15,000 117 (33.5) 53 (36.1)
  Unknown 5
Smoking status at cohort entry
  Current 253 (72.5) 102 (68.9)
  Former 75 (21.5) 40 (27.0)
  Never 21 (6.0) 6 (4.1)
Smokes (or smoked) menthol cigarettesc
  Yes 231 (70.6) 24 (17.1)
  No 96 (29.4) 116 (82.9)
  Unknown 7
Self-reported doctor diagnosis of emphysema  
or chronic bronchitis
  Yes 39 (11.1) 45 (30.2)
  No 312 (88.9) 104 (69.8)
  Unknown 1
First-degree relative with lung cancer
  Yes 26 (9.4) 28 (23.5)
  No 251 (90.6) 91 (76.5)
  Unknown 105
(Continued)
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By the end of study follow-up, 75% of identified lung 
cancer cases were deceased with a median overall survival of 
0.73 years. Kaplan–Meier product-limit survival estimates 
demonstrated blacks had shorter median survival times (0.67 
versus 1.02 years) and poorer overall survival compared with 
whites (p = 0.06, log-rank test; Fig. 2). Figure 3 illustrates the 
poor survival of black men compared with women and white 
men (p < 0.0001, log-rank test; Fig. 3). Age at diagnosis did not 
significantly impact survival (data not shown). After adjusting 
for disease stage, pack-years of smoking, age at diagnosis, 
sex, education, baseline body mass index, health insurance 
status, and study site, blacks and whites had no difference in 
mortality (HR = 0.99; 95% CI, 0.74–1.32; Table 2). Including 
an indicator for rural versus urban county of residence did not 
FIGURE 1.  Stage distribution for black and white incident 
non–small-cell lung cancer cases occurring from 2002 to 
2011 in Southern Community Cohort Study participants.
FIGURE 2.  Kaplan–Meier curves for black and white inci-
dent non–small-cell lung cancer cases occurring from 2002 to 
2011 in Southern Community Cohort Study participants.
TABLE 1. (Continued)
Characteristic
NSCLC Cases
N = 501
Black (n = 352) White (n = 149)
n (%) n (%)
  <25 160 (45.7) 50 (33.8)
  25–29 107 (30.6) 55 (37.2)
  ≥30 83 (23.7) 43 (29.1)
  Unknown 3
Health insurance status
  Uninsured 126 (36.1) 44 (29.7)
  Medicare, aged <65 yr 51 (14.6) 25 (16.9)
  Medicare, aged ≥65 yr 25 (7.2) 28 (18.9)
  Medicaid 88 (25.2) 27 (18.2)
  Private 42 (12.0) 22 (14.9)
  Military/other 17 (4.9) 2 (1.4)
  Unknown 4
Numbers may not add to 100% because of rounding.
aDate of last follow-up February 4, 2011.
bDate of diagnosis to date of last follow-up (or death).
cAmong current and former smokers only.
NSCLC, non–small-cell lung cancer; NOS, not otherwise specified.
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alter this finding (data not shown). Male lung cancer cases 
had a statistically significant 41% greater mortality compared 
with females (HR = 1.41; 95% CI, 1.10–1.80; Table 2). As 
expected, distant stage of disease at diagnosis was strongly 
associated with mortality, with almost a fivefold increased 
mortality compared with those diagnosed at localized stage 
(Table 2). No significant differences in mortality were found 
according to health insurance classification. Blacks (OR = 
0.72; 95% CI, 0.40–1.31), males (OR = 0.61; 95% CI, 0.35–
1.06), and those enrolled at a community health center (OR = 
0.55; 95% CI, 0.23–1.32) were less likely (although not sta-
tistically significant) to have localized stage of disease, after 
adjusting for pack-years of smoking, education, body mass 
index, and age of diagnosis.
DISCUSSION
This survival analysis of incident lung cancers nested 
within a large prospective cohort study of blacks and whites 
revealed greater crude mortality and shorter median survival 
for blacks compared with whites but no racial difference in 
overall mortality between low-income blacks and whites after 
controlling for stage of diagnosis. We were uniquely positioned 
to examine lung cancer mortality for both blacks and whites 
in the Southeastern United States after good control for SES, 
because both blacks and whites in the cohort had generally 
similar low household income, low education, health insurance 
and access to basic health services, with minor differences 
adjusted for in our statistical analyses. Our findings in this 
population of blacks and whites with similar individual-level 
SES are analogous to results of lung cancer investigations in 
other populations with similar access to health care or surgical 
treatment between blacks and whites12,17,18 or investigations 
stratified by cancer stage.19 Our findings provide evidence to 
support that when demographic factors, smoking, and lung 
cancer stage are controlled, lung cancer survival between black 
and white lung cancer patients is similar, even among primarily 
low-income and medically underserved populations. However, 
similar to national data,3 our study found an increased mor-
tality for males compared with females. This finding deserves 
further investigation to clarify predictors of local stage when 
clinical interventions are possible.
Prior research on racial disparities in lung cancer has 
found that blacks are more likely to be diagnosed at advanced 
FIGURE 3.  Kaplan–Meier curves for black and white incident 
non–small-cell lung cancer cases, stratified by sex, occurring 
from 2002 to 2011 in Southern Community Cohort Study 
participants.
TABLE 2.  All-Cause Mortality among Incident NSCLC Cases 
Participating in the Southern Community Cohort Study, 
2002–2011
Variable
NSCLC Cases
N = 424
HR 95% CI p
Race
  White 1.0 Referent
  Black 0.99 0.74–1.32 0.94
Smoking pack-years 1.005 1.00–1.009 0.04
Age at diagnosis 1.00 0.98–1.02 0.99
Sex
  Female 1.0 Referent
  Male 1.41 1.09–1.81 <0.01
Education, yr
  <12 1.0 Referent
  ≥12 1.04 0.81–1.33 0.79
BMI, kg/m2
  <25 1.0 Referent
  25–29 1.00 0.76–1.30 0.98
  ≥30 0.92 0.69–1.24 0.60
Health insurance status
  No 1.0 Referent
  Medicare, aged 
<65 yr
0.92 0.65–1.32 0.66
  Medicare, aged 
≥65 yr
0.72 0.44–1.20 0.21
  Medicaid 1.21 0.89–1.65 0.22
  Private 0.74 0.49–1.12 0.15
  Military/other 1.33 0.75–2.35 0.33
Disease stage
  Localized 1.0 Referent
  Regional 2.23 1.45–3.43 <0.01
  Distant 4.99 3.33–7.48 <0.01
Study site
  General population 1.0 Referent
  CHC 1.13 0.72–1.76 0.60
Cox proportional hazards analysis of lung cancer mortality among SCCS 
participants.
HR, hazard ratio; CI, confidence interval; NSCLC, non–small-cell lung cancer; 
CHC, community health center; SCCS, Southern Community Cohort Study; BMI, body 
mass index.
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stage of lung cancer compared with whites.10 Similarly, within 
the SCCS, we found that a greater percentage of blacks were 
diagnosed at advanced stage of disease compared with whites, 
despite having similar smoking status and access to basic 
health care. Research suggests blacks may tend to hold dif-
ferent beliefs regarding lung cancer treatments compared with 
whites, including inaccurate beliefs regarding tumor spread 
when surgically exposed to air,7 which may lead to a later 
stage of presentation. Diagnosis at an early stage of disease 
is crucial because lung cancers diagnosed at a localized stage 
have a 52% 5-year relative survival rate; however, only 15% 
of lung cancers are diagnosed at this early stage,3,11 consistent 
with the 16% of localized stage lung cancers identified in our 
study population.
Contrary to prior investigations by others,13,20,21 we did 
not find that the SES, measured using highest education level 
attained, was associated with localized stage of lung cancer. 
Lung cancer incidence is higher among poor and low-edu-
cation populations,14 yet few lung cancer studies have been 
devoted to underserved populations. It is well documented 
that educational attainment is associated with improved can-
cer survival such that poorly educated20,22 and low-income 
populations experience worse outcomes compared with 
higher-income populations.1,23 Several studies using census-
level data have found inverse associations between SES and 
lung cancer mortality.13,21,24 Using census block group data to 
construct an SES metric, Schwartz et al.13 found that SES pre-
dicted lung cancer stage at diagnosis, with individuals living 
in professional occupation block groups having a reduced 
mortality compared with individuals living in working poor 
block groups. Similarly, Erhunmwunsee et al.21 found indi-
viduals living in census tracts with lower incomes and less 
education had shorter survival compared with individuals 
living in regions with higher incomes or greater education 
level. However, these ecologic studies are constrained by the 
lack of data on important individual-level factors influencing 
survival, and ascribing attributes of a group to an individual 
can result in inaccurate inferences.25 Using U.S. mortality 
data and education data from the U.S. Current Population 
Survey, Albano et al.20 identified an increased mortality 
among blacks and whites diagnosed with lung cancer and 
having less than 12 years of education compared with those 
with 12 or more years, especially among men. However, 
where health care access has been universal and treatment 
has been similar, such as among military populations or clin-
ical populations, no racial differences in lung cancer survival 
between blacks and whites have been observed.12,17,18,26 Thus 
racial differences in lung cancer survival seem to manifest 
differently across populations, yet few have examined low-
income populations. Our study sheds light on low-income 
populations and indicates that blacks tend to be diagnosed 
with lung cancer at later stage and have poorer survival than 
whites, but when stage and other factors are controlled, racial 
differences disappear.
Our study is limited by a lack of assessment of treat-
ment received, treatment quality of care, and medically con-
firmed comorbidities. Although we do not have systematic 
treatment information available from clinical records, we 
were able to adjust for stage and health insurance status as a 
proxy for treatment. Our findings suggest that if lung cancer 
treatment differences do exist between blacks and whites in 
this low-income population, the influence on survival may be 
minimal. Comorbidities are important predictors of lung can-
cer stage, treatment, and survival.27,28 Our limited sample size, 
especially for whites, limits our statistical power, which may 
have resulted in less precision around our estimated HRs (i.e., 
wide CIs) and therefore our conclusions regarding statistically 
significant findings. Future studies are warranted to replicate 
our findings in larger populations of low-income blacks and 
whites, stratifying by histology and incorporating lung cancer 
treatment and comorbidities into analyses.
The strengths of our study are the inclusion of blacks 
and whites of similar low SES and incident lung cancer cases 
nested within a large prospective study. Notably, we obtained 
individual-level data on smoking and health insurance status, 
which prior studies using Surveillance Epidemiology and End 
Results cancer registry or census-level data have been unable 
to measure.10 Furthermore, data were obtained before lung 
cancer diagnosis, thus minimizing the possibility of recall 
bias. Few studies have focused on medically underserved 
populations having such low SES. Importantly, our findings 
may be generally applicable to low-income, underserved pop-
ulations thus filling an important research gap regarding lung 
cancer outcomes in groups frequently excluded from lung 
cancer investigations.
In summary, we observed that within an underserved 
population of blacks and whites of similar SES, blacks tend 
to be diagnosed with lung cancer at later stages of disease and 
have poorer overall survival, but after control for stage racial 
differences in mortality are no longer apparent. Regardless of 
race, the survival was low with 75% of the cases deceased 
over a mean 1.3 year follow-up period. The poor lung can-
cer prognosis remains true despite the steady decline in lung 
cancer incidence, declining smoking rates, increased aware-
ness of the disease in the general population, and the advent 
of new technologies to detect lung cancers in early stages of 
the disease. This has prompted the National Cancer Institute 
to prioritize research aimed at improving early diagnosis of 
disease29 and underscores the timeliness of the National Lung 
Screening Trial findings of improved survival associated with 
computed tomographic screening.30 It remains to be deter-
mined whether the observed difference in histologic subtype 
and stage of presentation of lung cancer between blacks and 
whites is because of differences in comorbidities, cultural 
choices between blacks and whites, potential underlying bio-
logic or genetic variations, or combinations of these factors. 
Importantly, these findings indicate that race per se may not 
be a predictor of poor survival, even among a primarily low-
income and medically underserved population. Future efforts 
should identify opportunities for early diagnosis and treat-
ment, especially for black males who experience a greater 
mortality from lung cancer.
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